AIM
VTYX

Aigen Investment Management’s Ventyx Biosciences VTYX Stock Holding History

Aigen Investment Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,238
Closed -$64.8K – 1037
2023
Q4 		$64.8K Buy
+26,238
New +$249K 0.01% 743

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Aigen Investment Management's VTYX Position: Q1 2024 in Review

Aigen Investment Management sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 26,238 shares — an estimated $64.8K sold.

Aigen Investment Management first reported a position in VTYX in Q4 2023 and held it in 1 quarter. The position peaked at $64.8K in Q4 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Aigen Investment Management reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 26,238 Ventyx Biosciences shares in Q1 2024, an estimated $64.8K.
  • Aigen Investment Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 1 quarter.
  • Aigen Investment Management's Ventyx Biosciences position peaked at $64.8K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.